# Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19

> **NCT04592549** · PHASE1 · COMPLETED · sponsor: **Alachua Government Services, Inc.** · enrollment: 48 (actual)

## Conditions studied

- SARS-CoV-2

## Interventions

- **DRUG:** ADM03820
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04592549
- **Lead sponsor:** Alachua Government Services, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-04
- **Primary completion:** 2023-10-06
- **Final completion:** 2023-10-06
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-03-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04592549

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04592549, "Study of Monoclonal Antibody Cocktail Being Tested for the Prevention of COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04592549. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*